Microsomal prostaglandin E 2 synthase-1 (mPGES-1) catalyzes the formation of prostaglandin E 2 (PGE 2 ) from the endoperoxide prostaglandin H 2 (PGH 2 ). Expression of this enzyme is induced during the inflammatory response, and mouse knockout experiments suggest it may be an attractive target for antiarthritic therapies. Assaying the activity of this enzyme in vitro is challenging because of the unstable nature of the PGH 2 substrate. Here, the authors present an mPGES-1 activity assay suitable for characterization of enzyme preparations and for determining the potency of inhibitor compounds. This plate-based competition assay uses homogenous time-resolved fluorescence to measure PGE 2 produced by the enzyme. The assay is insensitive to DMSO concentration up to 10% and does not require extensive washes after the initial enzyme reaction is concluded, making it a simple and convenient way to assess mPGES-1 inhibition. (Journal of Biomolecular Screening 2008:619-625) 
INTRODUCTION
T HERAPEUTIC INTERVENTION in the production of prostaglandins has been widely demonstrated as a potent mediator of pain and inflammation. This includes nonsteroidal anti-inflammatory agents such as aspirin that inhibit the cyclooxygenase (COX) enzymes. More recently, COX-2 selective inhibitors have been developed, although cardiovascular safety issues have been raised for this class of enzymes. 1, 2 Prostaglandin E 2 (PGE 2 ) synthase enzymes act downstream on the product of the COX enzymes (prostaglandin H 2 ; PGH 2 ) and act to shunt the pathway toward the production of PGE 2 . PGE 2 is the most abundant prostanoid in the body and is known to have multiple effects in inflammatory pathways. 3, 4 As PGE 2 is only 1 of many signaling molecules in the COX-dependent biosynthetic pathway, inhibition of PGE 2 synthases may have a different pharmacologic profile, including reduced toxicity associated with COX inhibition.
Although there are a number of proteins with PGE 2 synthase activity, expression of 1 enzyme (microsomal PGE 2 synthase-1) is dramatically induced during inflammatory responses, for example, stimulation with interleukin (IL)-1β or tumor necrosis factor alpha (TNFα). 5, 6 Increased microsomal PGE 2 synthase-1 (mPGES-1) levels are seen in the synovial tissue of patients with rheumatoid arthritis. 7 Furthermore, as mPGES-1 knockout mice are resistant to collagen-induced arthritis 8 and showed reduced severity of collagen-antibody--induced arthritis, 5 this enzyme represents an attractive target for the development of new arthritic therapies.
mPGES-1 is a small (17-kDa) protein belonging to an enzyme family known as membrane-associated proteins involved in eicosanoid and glutathione metabolism. 9, 10 The endoperoxidase activity of mPGES-1 requires glutathione to convert PGH 2 to PGE 2 . A reliable in vitro enzyme assay is an essential tool for drug discovery efforts targeting this protein. A significant challenge in the development of such an assay comes from the unstable nature of the PGH 2 substrate in aqueous media at room temperature. In the absence of any enzyme, PGH 2 can spontaneously convert to the product (PGE 2 ) catalyzed by mPGES-1 over the course of minutes, 11, 12 although this complicating factor can be slowed somewhat by reducing the temperature to ∼0 °C. 13 In vivo, the PGH 2 output of the COX enzymes is likely functionally coupled to various endoperoxidases including prostaglandin F 2 and D 2 synthases as well as E 2 synthase, thereby allowing multiple forms of prostaglandins to come from the same transient precursor.
A number of mPGES-1 enzyme assays have appeared in the literature. The most direct assay for PGE 2 synthase involves highperformance liquid chromatography (HPLC) measurements of substrate loss and concomitant product formation. 10, 13, 14 This method, however, is time-consuming and not very amenable to highthroughput means. Another enzyme assay has been reported that couples production of mPGES-1-catalyzed PGE 2 to 15-hydroxyprostaglandin dehydrogenase. 15 In this assay, spectrophotometric detection was employed to monitor NADH produced by 5-hydroxyprostaglandin dehydrogenase in a PGE 2 -dependent manner. Although this is a continuous assay, the coupling enzyme withstands DMSO concentrations only to 0.5% and can be inactivated by inhibitors that do not bind to mPGES-1. Finally, an antibodyderived competition assay for mPGES-1 used in a high-throughput screening campaign has been described. 16 That assay was run at room temperature and required very short reaction times (30 s) that can be impractical without extensive automation. Furthermore, being enzyme-linked immunosorbent assay (ELISA) based, this assay necessitated the use of extensive washes and long incubation periods following the initial enzyme reaction.
In this report, we describe a novel enzyme assay for mPGES-1 that uses homogenous time-resolved fluorescence (HTRF) to detect mPGES-1-produced PGE 2 . This employs a 2-phase procedure in which the enzymatic reaction is performed and quenched, followed by quantification of the PGE 2 product. We demonstrate that this assay, which requires a dilution step followed by direct incubation with the HTRF reagents, is flexible for use in evaluating the mPGES-1 enzyme and can be used to interrogate the potency of mPGES-1 inhibitor compounds.
MATERIAL AND METHODS

Reagents
Potassium phosphate, sodium chloride, glycerol, and glutathione were purchased from Sigma-Aldrich (St. Louis, MO), noctylglucoside was purchased from EMD Chemicals/Calbiochem (San Diego, CA), and diheptanoylphosphatidylcholine (DHPC) was purchased from Avanti Polar Lipids (Alabaster, AL). Macroprep Ceramic Hydroxyapatite (Type 1, 40 μm) was purchased from Bio-Rad Laboratories (Hercules, CA). PGH 2 (supplied at 0.5 mg/mL in acetone) was purchased from BIOMOL (Plymouth Meeting, PA). This was stored at -80 °C until immediately before use in the assay. Anti-PGE 2 HTRF kits containing anti-PGE 2 -antibody cryptate and PGE 2 -d2 conjugate and PGE 2 used as standard were purchased from Cisbio (Bedford, MA).
Baculovirus cloning and expression of human mPGES-1
Gateway primers (primer 1: 5′-GGGGACAAGTTTGTACAA-AAAAGCAGGCTGCCACCATGCCTGCCCACAGCCTG-3′; primer 2: 5′-GGGGACCACTTTGTACAAGAAAGCTGGGT-TCACAGGTGGCGGGCCGC-3′) were designed to allow the amplification of the ORF of human mPGES-1 cDNA sequence (GenBank accession no. NM_004878) from MGC clone no. 10317, image no. 3623516 (Invitrogen, Carlsbad, CA) and subsequent subcloning into Gateway vector pDEST8 (Invitrogen). The mPGES-1 recombinant bacmid and the initial recombinant baculovirus were obtained by use of the Invitrogen Bac-to-Bac expression system according to protocols from the manufacturer. After generation of recombinant bacmid and baculovirus stock, 50 mL of Sf9 cells (2 × 10 6 cells/mL) were infected with mPGES-1 virus stock. Western blot analysis of lysates from small-scale test cultures showed that maximal mPGES-1 expression occurred at 48 h postinfection ( Fig. 1a) . For scale-up expression, 2 × 10 L Sf9 cells were cultured in Sf-900 II media (Invitrogen) at 27.5 °C in a Wave20 bioreactor (Wave Biotech, Inc/GE Healthcare) operating at 22.5 rpm. When cell density reached 2 × 10 6 cells/mL, the cultures were infected with high-titer mPGES-1 baculovirus stock. Cells were harvested by pelleting at 48 h postinfection and stored at -80°C for purification.
Protein purification
Purification was adapted from conditions published by Ouellet and others. 13 Briefly, cell pellets were suspended in a solution containing 250 mM sucrose, 15 mM Tris pH 8.0, 0.1 mM EDTA, and 1 mM glutathione and lyzed using a 25-mm Branson sonicator (Branson, Danbury, CT) for approximately 600 pulses with temperature maintained between 4 °C and 7 °C. Coulter, Fullerton, CA) rotor at 5000g. The pellet was frozen, and the supernatant was ultracentrifuged in a Ti70 (Beckman Coulter) rotor at 120,000g for 1 h to improve recoveries. The 120,000g pellet was solubilized via stirring and sonication using a 3-mm Branson probe in 10% glycerol, 10 mM potassium phosphate, pH 7.0, 1 mM glutathione, (Fig. 1b) . The full-length, unmodified protein at 17,103 Da was also observed in lower abundance (∼15%).
HTRF mPGES-1 enzyme assay
Enzyme reactions were conducted on wet ice in Corning 96well half-area polystyrene plates (catalog no. 3694; Lowell, MA). Reaction volumes of 20 μL typically contained 0.5 to 2 ng/well (1.5-6 nM) mPGES-1 and 28 μM PGH 2 in 5% DMSO, 2% acetone, 3 mM reduced glutathione, 100 mM sodium phosphate pH 7.0, 0.5 mM EDTA. Cold PGH 2 in acetone was added to reaction buffer prechilled on ice immediately before initiating the reaction. Because conversion of PGH 2 to PGE 2 occurs appreciably even at 0 °C, we employed short reaction times in our assay. Reactions were stopped typically after 5 min by the addition of 5 μL 12 mg/mL SnCl 2 made fresh in 62 mM HCl. (Precipitation was often observed once SnCl 2 was added to reaction samples but did not interfere with the assay.)
Samples were diluted 1:10,000 in PGE 2 dilution buffer (50 mM sodium phosphate pH 7.0, 0.02% bovine serum albumin) by serial dilutions in Corning 96-well round bottom plates (catalog no. 3365). Twenty-five microliters of diluted sample was removed and combined with 12.5 μL anti-PGE 2 -antibody cryptate (HTRF donor) and 12.5 μL PGE 2 -d2 (HTRF acceptor) in Corning 96-well half-area polysterene plates (catalog no. 3694). After incubating at 4 °C overnight, the fluorescence at 620 nm and 665 nm was read on a RUBYstar HTRF microplate reader (BMG Labtech, Durham, NC) using a ∼50-microsecond delay following an excitation pulse at 337 nm. HTRF ratios were defined as fluorescence signal at 665 nm divided by fluorescence signal at 620 nm multiplied by 10,000. (An interpretable HTRF signal can be obtained after incubating plates for 1 h at room temperature, but we found that overnight incubation at 4 °C gave better quality data.) Data were converted from HTRF ratio values to PGE 2 concentration via an 8-to 12-point standard curve from 2500 pg/mL to 0 pg/mL PGE 2 . Linear extrapolation via GraphPad Prism software (San Diego, CA) between each point on the standard curve was used to determine the PGE 2 concentration. Correction for 10,000-fold dilution of samples and the molecular weight of PGE 2 (352.5 g/mol) allowed conversion from pg/mL concentrations in diluted samples to PGE 2 concentrations (μM) in the source reactions with enzyme.
IC 50 s were calculated by fitting the following equation in GraphPad Prism:
where X is the total inhibitor concentration, Y is the PGE 2 product formed, and Max is the PGE 2 product generated in the absence of inhibitor.
RESULTS AND DISCUSSION
HTRF competition method for PGE 2 detection
We sought a convenient, accurate means to determine PGE 2 produced by mPGES-1 catalysis for inhibitor characterization. After examining the commercially available detection options, which include a colorimetric enzyme immunoassay, chemiluminescent fluorescence polarization immunoassay, and fluorescent microspheres, we turned to HTRF-based detection because of its sensitivity and ease of use. In this technique, a cryptate-linked (donor) antibody specifically recognizing PGE 2 binds a PGE 2 -d2 (acceptor) conjugate. When the 2 fluorophores are brought into proximity, time-resolved fluorescence resonance energy transfer occurs ( Fig. 2a) . This detection method relies on competitive binding from exogenous, free PGE 2 to disrupt the donor-acceptor complex. Therefore, the observed HTRF signal decreases with increasing amounts of enzyme-produced PGE 2 (Fig. 2b) . As is typical for HTRF, the long lifetime of the donor fluorophore employed minimizes complicating fluorescence from buffer compounds or test compounds.
The vendor reports that the cross-reactivity of the anti-PGE 2 antibody is less than 0.01% for prostaglandin D 2 and ∼2% for prostaglandin PGF 2α . To assess the usefulness of these reagents and the stability of PGH 2 in our desired assay buffer, we measured the nonenzymatic conversion of PGH 2 to PGE 2 by HTRF at room temperature (∼25°C) and on ice (∼0 °C; Fig. 2c ). The addition of SnC1 2 , which efficiently converts all remaining PGH 2 to prostaglandin F 2α (PGF 2α ), was used to quench the reactions. Our HTRF results indicate the conversion to PGE 2 occurs more rapidly at room temperature. This is in good agreement with measurements of the half-life of PGH 2 made using reversed-phase HPLC (∼5 min at room temperature, ∼60 min on ice; data not shown) as well as with previously published values for the nonenzymatic conversion of PGH 2 to PGE 2 . [11] [12] [13] Furthermore, the data in Figure 2c indicate that the HTRF reagents performed well at the 1:10 4 dilution scheme chosen for the experiment and that SnCl 2 can be used without compromising the sensitivity of HTRF detection.
Purified mPGES-1 is active
mPGES-1 enzyme was expressed in insect cells and purified to ∼80% homogeneity as described in the Materials and Methods section. A titration of this protein demonstrated good activity in our enzyme assay (Fig. 3) . The top panel shows the raw HTRF ratio as a function of enzyme concentration. Note that because the HTRF detection method is a competition assay (in which the observed signal is inversely proportional to PGE 2 concentration), even small amounts of PGE 2 from nonenzymatic formation lead to substantial decreases in the HTRF ratio. However, once the HTRF ratio is converted to PGE 2 concentration via the use of a standard curve (see the Materials and Methods section), nonenzymatic conversion clearly contributes weakly to total PGE 2 concentration (bottom panel in Fig. 3) when an assay time of 5 min is used.
We confirmed that this enzyme preparation requires use of a glutathione cofactor as expected for mPGES-1 (Fig. 4a) , providing confidence that we are measuring the relevant activity in our assay. Although enzyme activity was comparable from 0.5 to (c) Stability of prostaglandin H 2 (PGH 2 ) as measured by HTRF detection. A total of 28 μM PGH 2 was incubated in 100 mM sodium phosphate pH 7.0, 3 mM glutathione, 0.5 mM EDTA, 5% DMSO, 2% acetone on ice or at room temperature and quenched via the addition of SnCl 2 to 3 mg/mL at the times indicated. The plotted PGE 2 concentrations were determined following a 1:10,000 dilution. 4 mM glutathione (data not shown), 3 mM glutathione was used as a standard condition for our assay. Time-course experiments showed reasonably linear kinetics over 5 min (Fig. 4b) at enzyme concentrations between 0.5 and 1.5 ng/well. For experimental convenience, 5 min was selected as the standard reaction time. Our preparation of mPGES-1 shows a specific activity of ∼50 μmol PGE 2 produced/min/mg enzyme, which exceeds that described by Ouellet and others 13 for similar conditions (∼5 μmol PGE 2 /min/mg). By titrating PGH 2 substrate into the reaction, we obtained the curve seen in Figure 4c . It is difficult to run this assay at concentrations >70 μM PGH 2 , presumably because small amounts of background PGE 2 contaminants present in the PGH 2 substrate stock swamp the signal of the enzyme-produced PGE 2 . However, a crude fit of the data in Figure 4c implies an approximate K m value of ∼10 to 30 μM for PGH 2 , which is in reasonable agreement with an earlier reported value of 15 μM. 13 To allow for IC 50 measurements of similar magnitude to K i for competitive inhibitors (and for experimental convenience), we selected a standard assay condition of 28 μM PGH 2 .
Enzyme tolerates DMSO and is activated by octylglucoside
Inhibitor compounds are routinely solubilized and provided in DMSO. To ensure that our assay could withstand inclusion of moderate amounts of this solvent, we examined the effects of DMSO (Fig. 5a) . Addition of 5% or 10% DMSO had no appreciable effect on the activity of mPGES-1, and 5% was selected as our standard condition.
Because the enzyme purification was conducted in detergent and because mPGES-1 is a membrane-associated protein, we evaluated the ability of a detergent (n-octylglucoside) to affect enzyme activity. As observed by Ouellet and others, 13 (a detergent not believed to be a cofactor for mPGES-1 catalysis) increased the rate of catalysis from mPGES-1 approximately 5fold (Fig. 5b) , and we found that this boost in activity was insensitive to the addition of 5% DMSO. Given that the detergent activates the enzyme, this may suggest n-octylglucoside will stabilize the enzyme and/or better mimic the true cellular environment of mPGES-1 (a membrane-associated protein). However, as described below, inclusion of this detergent also led to dramatic changes in potencies of inhibitor compounds, which may stem from hydrophobic elements of the inhibitors binding to the detergent and preventing access to the enzyme. Therefore, the use of noctylglucoside in inhibitor screening was not routinely used.
Evaluation of reference inhibitors
Two previously described mPGES-1 inhibitors were used to confirm the ability of this assay to measure inhibitor potency.
Compound 23 from Riendeau and others 17 and MK-886 have been reported to inhibit mPGES-1 enzyme with IC 50 s of 7 nM and 1.6 μM. We found very similar IC 50 s with our HTRF assay (15 nM and 6 μM; Fig. 6a ). Two negative control inhibitors (indomethacin and celecoxib) targeting the COX enzymes upstream in the biosynthetic pathway showed essentially no inhibition over the concentration ranges tested (Fig. 6b) . When we measured inhibition from Compound 23 and MK-886 in the presence of 2% octylglucoside, however, we saw large losses in apparent potency such that inhibition from MK-886 was no longer detectable and the IC 50 for Compound 23 became >10 μM. Compound 23 has been reported to have activity inhibiting PGE 2 production in A549 cells with an EC 50 of 490 nM. 17 Therefore, although an upshift in potency might be observed in vivo, this is substantially less than what we observed in the enzyme assay in the presence of octylglucoside. These results may stem from nonspecific binding of inhibitors to the detergent and reduce the ability of the assay to identify mPGES-1 inhibitors. Consequently, we do not advise using octylglucoside during inhibition studies.
In conclusion, we have developed a simple HTRF-based enzyme assay for mPGES-1. This is suitable for characterization of inhibitors and is capable of processing many samples simultaneously. Because of its homogenous nature, this platebased method does not use extensive washing, requiring only sample dilution and addition of HTRF detection reagents after completion of the enzyme reaction.
